You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 5,538,879


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,538,879
Title: Expression cassette and plasmids for a guard cell specific expression and their use for the introduction of transgenic plant cells and plants
Abstract:A method of and plasmids for producing specific gene expression in the guard cells of plants. In particular, 5\' transcriptional regulatory promoter regions are provided for guard cell specific expression. In addition, methods for preparing an expression cassette, plasmids, and the use of the cassettes and plasmids to produce transgenic plant cells and plants are described.
Inventor(s): Muller-Rober; Bernd (Berlin, DE), Sonnewald; Uwe (Berlin, DE), Willmitzer; Lothar (Berlin, DE)
Assignee: Institut fur Genbiologische Forschung Berlin GmbH (DE)
Application Number:08/140,180
Patent Claims:1. A recombinant double stranded DNA molecule comprising an expression cassette comprising:

i) a 5' transcriptional regulatory region, wherein said 5' transcriptional regulatory region comprises the DNA sequence of Seq I.D. No. 1; and

ii) a DNA fragment operably linked to said 5' transcriptional regulatory region, wherein said 5' transcriptional regulatory region leads to specific expression of said DNA fragment only in guard cells and not in mesophyllic or epidermal cells of leaves of transformed plants.

2. A recombinant double stranded DNA molecule according to claim 1, wherein said 5' transcriptional regulatory region is the 5' transcriptional regulatory region of a gene coding for ADP glucose pyrophosphorylase.

3. A recombinant double stranded DNA molecule according to claim 1, wherein said 5' transcriptional regulatory region is isolated from Solanum tuberosum.

4. A recombinant double stranded DNA molecule according to claim 1, wherein said 5' transcriptional regulatory region is the 3.2 kb HincII/BglII fragment contained in the plasmid pAS, deposited as DSM 6906.

5. A recombinant double stranded DNA molecule according to claim 1, wherein said DNA fragment is linked to the 5' transcriptional regulatory region in sense orientation.

6. A recombinant double stranded DNA molecule according to claim 1, wherein said DNA fragment is linked to the 5' transcriptional regulatory region in anti-sense orientation.

7. A recombinant double stranded DNA molecule according to claim 1, wherein said DNA fragment contains an open reading frame.

8. A recombinant double stranded DNA molecule according to claim 1, wherein said DNA fragment is from a genomic sequence.

9. A recombinant double stranded DNA molecule according to claim 1, wherein said DNA fragment includes an intron.

10. A recombinant double stranded DNA molecule according to claim 1, wherein said DNA fragment includes a non-coding leader sequence.

11. Plasmid pAS, deposited as DSM 6906.

12. Plasmid pAS-GUS, deposited as DSM 6907.

13. A method for the production of transgenic plants that show expression of a desired DNA sequence specifically in guard cells, comprising the steps of:

a) producing an expression cassette which comprises the following sequences

i) a 5' transcriptional regulatory region, wherein said 5' transcriptional regulatory region comprises the DNA sequence of Seq I.D. No. 1,

ii) a first DNA fragment operably linked to said 5' transcriptional regulatory region, and

iii) a second DNA fragment ensuring termination of transcription and polyadenylation of the resulting transcript,

b) transferring said expression cassette into plant cells, thereby producing transformed plant cells and

c) regenerating whole transgenic plants from the transformed cells.

14. A method according to claim 13, wherein said 5' transcriptional regulatory region is isolated from a Solanum tuberosum gene coding for ADP glucose pyrophosphorylase.

15. A method according to claim 13, wherein said 5' transcriptional regulatory region is the 3.2 kb HincII/BglII fragment contained in the plasmid pAS, deposited as DSM 6906.

16. A method according to claim 13, wherein said first DNA fragment is linked to the 5' transcriptional regulatory region in sense orientation.

17. A method according to claim 13, wherein said first DNA fragment is linked to the 5' transcriptional regulatory region in anti-sense orientation.

18. A method according to claim 13, wherein said first DNA fragment contains an open reading frame.

19. A method according to claim 13, wherein said first DNA fragment is from a genomic sequence.

20. A method according to claim 13, wherein said first DNA fragment includes an intron.

21. A method according to claim 13, wherein said first DNA fragment includes a non-coding leader sequence.

22. A transgenic plant or plant tissue regenerated from a cell according to claim 13.

23. A plant cell containing a recombinant double stranded DNA molecule according to claim 1.

24. A transgenic plant or plant tissue containing cells according to claim 23.

25. A transgenic plant according to claim 24, wherein said plant is a potato plant.

26. A transgenic plant according to claim 24, wherein said plant is a tomato plant.

27. A transgenic plant according to claim 24, wherein said plant is a tobacco plant.

28. A transgenic plant according to claim 24, wherein said plant is a sugar beet plant.

Details for Patent 5,538,879

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2013-07-23
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2013-07-23
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2013-07-23
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.